EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launchbenzinga.comPelthos Therapeutics acquires U.S. rights to Xepi Cream and raises $18 million to fund its relaunch and expand dermatology product offerings.
Get insights into the top gainers and losers of Monday's pre-market session.chartmill.comDiscover the top movers in Monday's pre-market session and stay informed about market dynamics.
